(Last Updated On: April 2, 2019)

Authors: Michael Vince D. Busa, MD, DPDS, Janice Natasha C. Ng, MD, DPDS, Maricarr Pamela M. Lacuesta-Gutierrez, MD, FPDS

Abstract

Background: Acne vulgaris is a common dermatologic disorder caused by follicular colonization of Propionibacterium acnes leading to inflammation. Enzymatic virgin coconut oil monoglyceride has been shown to have anti-inflammatory effects and antimicrobial activity against Propionibacterium acnes.

Objectives: To compare the efficacy and safety of enzymatic virgin coconut oil monoglyceride (EVCO) 2% cream versus benzoyl peroxide (BPO) 5% cream in the treatment of mild to moderate acne vulgaris.

Methods: 100 participants with mild to moderate acne or a rating of 2 or 3 in the Investigator’s Global Assessment (IGA) for acne were randomized to receive either EVCO 2% cream or BPO 5% cream applied on the face twice daily over an 8-week period. Primary outcomes measured in the study were clearance rate graded as “clear” or “almost clear” (rating of 0 or 1) based on the IGA and adverse reaction rate.

Results: At week 8, the clearance rate was achieved in 56% (28/50) of participants in the BPO group and 46% (23/50) in the EVCO group. The difference between the two groups was not statistically significant (p=0.319). Adverse reactions observed in the BPO group were erythema (16%), pruritus (14%), scaling (12%), dryness (6%) and burning/stinging (6%) and while in the EVCO group only burning/stinging (2%) was noted; however, this was not statistically significant (p=0.1806).

Conclusion: EVCO 2% cream is an efficacious and safe alternative treatment for acne vulgaris

 

Citation

Busa MV, Ng JN, Lacuesta-Gutierrez MP. A prospective, randomized, double-blind, comparative study on the efficacy and safety of 2% enzymatic virgin coconut oil monoglyceride cream versus 5% benzoyl peroxide cream in the treatment of mild to moderate acne vulgaris. J Phil Dermatol Soc. 2018; 27(2): 18-30.

 

Keywords

acne vulgaris, enzymatic virgin coconut oil, benzoyl peroxide

1. Schmidt N, Gans EH. Clindamycin 1.2% tretinoin 0.025% gel versus clindamycin gel treatment in acne patients: a focus on Fitzpatrick skin types. J Clin Aesthet Dermatol. 2011 Jun;4(6):31.
2. Simonart T. Newer approaches to the treatment of acne vulgaris. Am J Clin Dermatol [Internet]. 2012 Dec 1[cited 2015];13(6):357-64.
3. Zaenglein AL, Graber EM, Thiboutot DM. Acne vulgaris and acneiform eruptions. In: Goldsmith L, Katz S, editors. Fitzpatrick’s dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012:897-917.
4. Zaenglein AL, Thiboutot DM. Acne vulgaris. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Edinburgh: Elsevier; 2012: 545-559
5. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003 Sep 30;49(3): S200-10.
6. Philippine Dermatological Society Health Information Systems. Philippine Dermatological Society. c2011 [updated July 20, 2016; cited July 30, 2016]. Available by request from: pdshis@outlook.com
7. Delima C, Belisario M, Bunagan M. A randomized investigator-blinded clinical trial evaluating the efficacy and safety of Ocimum basilicum (Sweet Basil) 2% cream vs benzoyl peroxide 5% cream in the treatment of mild to moderate acne vulgaris. Philippines. Forthcoming 2010.
8. Bozzo P, Chua-Gocheco A, Einarson A. Safety of skin care products during pregnancy. Can Fam Physician. 2011 Jun 1;57(6):665-7.
9. Wolverton S. Comprehensive Dermatologic Drug Therapy. 3rd ed. Edinburgh: Elsevier; 2012. 545-559.
10. Elmore LK, Nance G, Singleton S, Lorenz L. Treatment of dermal infections with topical coconut oil. Natural Medicinal Journal [Internet]. 2014 May [cited 2015];6(5): [about 3 p.]
11. Mansor TS, Che Man YB, Shuhaimi M, Abdul Afiq MJ, Ku Nurul FK. Physicochemical properties of virgin coconut oil extracted from different processing methods. International Food Research Journal [Internet].2012 [cited 2015];19(3):837-45.
12. Monte RM, Pilones EV, Bordallo MA, Noble AM, Canela GO. Anti-inflammatory activity of virgin coconut oil. Philippine Journal of Internal Medicine. 2007 Mar; 45 (2); 85-88.
13. Nakatsuji T, Kao MC, Fang JY, Zouboulis CC, Zhang L, Gallo RL, et al. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol. 2009 Oct 1;129(10):2480-8.
14. Espino TM, et al. Production of virgin coconut oil and lipase catalyzed synthesis of B-monoglycerides. Philippines. Forthcoming 2004.
15. Verallo-Rowell VM. Rx: Coconuts! (The Perfect Health Nut). USA: Xlibris; 2005.
16. Reuter J, Merfort I, Schempp CM. Botanicals in dermatology. Am J Clin Dermatol [Internet]. 2010 Aug 1[cited 2015];11(4):247-67.
17. Bawalan DD, Chapman KR. Virgin coconut oil production manual for micro-and village-scale processing [Internet] Bangkok: Thammada Press Co. Ltd; 2006 [cited 2016 Sep 8].
18. DebMandal M, Mandal S. Coconut (Cocos nucifera L.: Arecaceae): in health promotion and disease prevention. Asian Pacific journal of tropical medicine. 2011 Mar 31;4(3):241-7.
19. Kabara JJ, Swieczkowski DM, Conley AJ, Truant JP. Fatty acids and derivatives as antimicrobial agents. Antimicrobial agents and chemotherapy. 1972 Jul 1;2(1):23-8.
20. Haris HH, Ming YK, Moon TK, Kim NS, Bum LC, Kotak V, et al. Evaluation of efficacy and safety of AVCO acne gel for acne: an open, single centric, non comparative study for 8 weeks. Asian J Pharm Clin Res. 2012; 5:73-76.
21. Pineda-DLS JP, Verallo-Rowell VM. Open study on the safety and efficacy of 2% monolaurin gel in the treatment of mild to moderate inflammatory facial acne vulgaris. Philippines. Forthcoming 2004.
22. Verallo-Rowell VM, et. al. A vehicle controlled trial on the safety and efficacy of 2% monolaurin gel in the treatment of mild to moderate inflammatory facial acne vulgaris. Philippines. Forthcoming 2004.
23. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry; Acne Vulgaris: Developing Drugs for Treatment (2005).
24. Thiboutot D, Pariser DM, Egan N, Flores J, Herndon JH, Kanof NB, et al. Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial. J Am Acad Dermatol. 2006 Feb 28;54(2):242-50.
25. Tan JK. Current measures for the evaluation of acne severity. Expert Review of Dermatology. 2008 Oct 1;3(5):595-603.
26. Gold LS, Tan J, Cruz-Santana A, Papp K, Poulin Y, Schlessinger J, et al. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis. 2009 Aug 1;84(2):110-6.
27. Iftikhar U, Aman S, Nadeem M, Kazmi AH. A comparison of efficacy and safety of topical 0.1% adapalene and 4% benzoyl peroxide in the treatment of mild to moderate acne vulgaris. Journal of Pakistan Association of Dermatologists. 2009; 19: 141-145.
28. Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Am J Clin Dermatol. 2001 Feb 1;2(1):33-9.
29. Bissonnette R, Bolduc C, Seité S, Nigen S, Provost N, Maari C, et al. Randomized study comparing the efficacy and tolerance of a lipophillic hydroxy acid derivative of salicylic acid and 5% benzoyl peroxide in the treatment of facial acne vulgaris. J Cosmet Dermatol. 2009 Mar 1;8(1):19-23.
30. Papageorgiou PP, Chu AC. Chloroxylenol and zinc oxide containing cream (Nels cream®) vs. 5% benzoyl peroxide cream in the treatment of acne vulgaris. A double-blind, randomised, controlled trial. Clinical and experimental dermatology. 2000 Jan 1;25(1):16-20.
31. Riegelman RK. Studying a Study and Testing a Test: Reading Evidence-Based
Health Research. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2012
32. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. The Cochrane Collaboration; 2011.

More Articles

A randomized, double-blind, comparative study on the safety and efficacy of virgin coconut (Cocos nucifera l.) oil against 1% hydrocortisone lotion as an anti-inflammatory and antipruritic preparation for mosquito reactions

  Authors: Uy, Veronica S, MD; Gracia B. Teodosio, MD, FPDS; Ma. Teresita G. Gabriel, MD, FPDS; Mary Catherine T. Galang, MD; Mohammad Yoga A. Waskito, MD; Johannes F. Dayrit, MD, FPDS     Abstract Background: Virgin coconut oil (VCO) has been reported...

read more